Solara Active Pharma Sciences Ltd Share Price Today - Solara Active Pharma Sciences Ltd Stock Price Live NSE/BSE

Solara Active Pharma Sciences Ltd

NSE: SOLARA BSE: 541540

₹485.80

(0.92%)

Sat, 11 Apr 2026, 01:23 pm

MTF 5xInvest in Solara Active Pharma Sciences Ltd with 5x Leverage Buy with MTF

Market Cap23.15B

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Solara Active Pharma Sciences Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1757.09
Net Profit
0.54
P/B
1.89
Sector P/E
31.77
P/E
3943.85
EV/EBITDA
13.31
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
9.71
ROCE (Industry)
13
RONW (Industry)
12.31
ROE
0.05
ROCE
5.41
Debt/Equity
0.89
EPS (TTM)
0
Dividend Yield
0
Book Value
344.59
Interest Cover
1

Analysis

all

Pros

Solara Active Pharma Sciences's earnings growth is expected to exceed the low risk savings rate of 7.2%.
Solara Active Pharma Sciences's earnings are expected to exceed the low risk growth rate next year.
An improvement in Solara Active Pharma Sciences's performance (ROE) is expected over the next 3 years.
Solara Active Pharma Sciences's revenue growth is expected to exceed the India market average.
Solara Active Pharma Sciences is profitable, therefore cash runway is not a concern.

Cons

Solara Active Pharma Sciences is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
No need to calculate the sustainability of Solara Active Pharma Sciences's dividends as it is not paying a notable one for India.
Solara Active Pharma Sciences is not paying a notable dividend for India, therefore no need to check if the payments are stable.
Solara Active Pharma Sciences's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Solara Active Pharma Sciences's dividend is below the markets top 25% of dividend payers in India (3.08%).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	42.00	42.01	42.01	37.94	37.23
FII	11.98	13.58	14.25	14.63	14.67
DII	3.64	2.69	2.62	2.61	3.19
Public	42.37	41.72	41.11	44.81	44.91
Government	0.00	0.00	0.00	0.00	0.00

Technical Analysis

RSI

59.05

MACD

2.77

50 DMA

472.08

200 DMA

569.65

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	556.18	499.18	462.37	442.18	405.37	385.18	328.18
Fibonacci	499.18	477.41	463.96	442.18	420.41	406.96	385.18
Camarilla	441.23	436	430.78	442.18	420.32	415.10	409.88

Pivots Level: Classic

+114.00

556.18

+57

499.18

+20.18

462.37

442.18

Pivot Point

LTP: 485.80

-36.82

405.37

-57

385.18

-114

328.18

Moving Average

SMAEMA

Period

Value

10-EMA
469.06
20-EMA
463.26
30-EMA
465.52
50-EMA
477.18
100-EMA
506.26
200-EMA
536.91

Announcement Date	Purpose	Action	Ex Date
06 Feb 2026	board-meetings	Quarterly Results
05 Nov 2025	board-meetings	Quarterly Results
03 Sept 2025	agm
29 Aug 2024	agm
17 Aug 2024	agm	Annual General Meeting	18 Sept 2024
09 May 2024	rights	1:3 Rights Issue of Equity Shares	15 May 2024
15 Apr 2024	rights	Right Issue of Equity Shares	15 May 2024
21 Aug 2023	agm
08 Aug 2023	agm	Annual General Meeting	09 Sept 2023
28 Jul 2022	agm

Solara Active Pharma Sciences Ltd

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Lupin Ltd

Divis Laboratories Ltd

Solara Active Pharma Sciences Ltd About

Solara Active Pharma Sciences offers a diversified portfolio of high-value commercial APIs across more than 70 countries.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2017

Headquarters

CEO

RAJAGOPALAN RAMAKRISHNAN

Employees

Contact

Website

http://www.solara.co.in

investors@solara.co.in

Phone

91-22-27892924

Location

201 Devavrata Sector 17 Vashi, Navi Mumbai, Mumbai, Maharashtra, 400703

Year	History
2017	The company was originally incorporated as SSL Pharma Sciences Limited under the Companies Act, 2013. The company's name was changed to Solara Active Pharma Sciences Limited and a fresh certificate of incorporation was issued by the RoC.
2019	Solara Active Pharma Sciences successfully completed the US FDA inspection at the multi-product manufacturing facility at Cuddalore with zero 483s.
2021	Solara Active Pharma approved the acquisition of the balance 10.77% stake in Sequent Penems.
2023	Solara Active Pharma Sciences completed the WHO inspection at its Cuddalore facility.
2024	The company issued rights shares of Rs. 10 in the ratio of 1:3 at a premium of Rs. 365 per share.

Client Name	Order Side	QTY	Avg Price	Date
FSSA INDIAN SUBCONTINENT FUND	Sell	224730	538.11	20 Jun 2025
PRONOMZ VENTURES LLP	Buy	2000000	495	16 Jun 2025
SPIRACCA VENTURES LLP	Sell	2000000	495	16 Jun 2025
AARTI BHATIA	Buy	204527	490	24 Feb 2025
BHATIA SURESH	Sell	204527	490	24 Feb 2025
TPG GROWTH IV SF PTE LTD	Sell	2000000	495	28 Jun 2024
AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITED	Buy	2000000	495	28 Jun 2024
MICROCURVES TRADING PRIVATE LIMITED	Buy	224655	587.89	22 Apr 2024
HRTI PRIVATE LIMITED	Buy	241797	587.59	22 Apr 2024
QE SECURITIES LLP	Buy	236554	588.86	22 Apr 2024

Solara Active Pharma Sciences Ltd News

Solara Issues Second & Final Call Notice

Solara Active Pharma Sciences dispatches second and final call notice to partly paid rights shareholders for ₹112.50 per share payment, with record date April 02, 2026 and payment period from April 23 to May 07, 2026.

08 Apr 2026

companies

Solara Publishes Newspaper Ads for Rights Issue Final Call

Solara Active Pharma Sciences published newspaper advertisements informing shareholders about the second and final call of ₹112.50 per share with record date April 2, 2026.

25 Mar 2026

companies

Solara Active Pharma Opens Special Window for Share Transfer

Solara Active Pharma Sciences announces special window for re-lodgement of physical share transfer requests from February 5, 2026 to February 4, 2027, following SEBI circular guidelines.

25 Mar 2026

companies

Solara Approves ₹112.50 Final Call on Rights Shares

Solara Active Pharma Sciences approves final call of ₹112.50 per share for partly-paid rights shares with record date set for April 2, 2026, completing rights issue process.

24 Mar 2026

companies

Solara Approves ₹112.50 Final Call on Rights Shares

Solara Active Pharma Sciences approves final call of ₹112.50 per share for partly-paid rights shares with record date set for April 2, 2026, completing rights issue process.

24 Mar 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800